Genetic Determinants of Antibiotic Resistance in Francisella
Open Access
- 12 May 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Microbiology
Abstract
Tularemia, caused by Francisella tularensis, is endemic to the northern hemisphere. This zoonotic organism has historically been developed into a biological weapon. For this Tier 1, Category A select agent, it is important to expand our understanding of its mechanisms of antibiotic resistance (AMR). Francisella is unlike many Gram-negative organisms in that it does not have significant plasmid mobility, and does not express AMR mechanisms on plasmids; thus plasmid-mediated resistance does not occur naturally. It is possible to artificially introduce plasmids with AMR markers for cloning and gene expression purposes. In this review, we survey both the experimental research on AMR in Francisella and bioinformatic databases which contain genomic and proteomic data. We explore both the genetic determinants of intrinsic AMR and naturally acquired or engineered antimicrobial resistance as well as phenotypic resistance in Francisella. Herein we survey resistance to beta-lactams, monobactams, carbapenems, aminoglycosides, tetracycline, polymyxins, macrolides, rifampin, fosmidomycin, and fluoroquinolones. We also highlight research about the phenotypic AMR difference between planktonic and biofilm Francisella. We discuss newly developed methods of testing antibiotics against Francisella which involve the intracellular nature of Francisella infection and may better reflect the eventual clinical outcomes for new antibiotic compounds. Understanding the genetically encoded determinants of AMR in Francisella is key to optimizing the treatment of patients and potentially developing new antimicrobials for this dangerous intracellular pathogen.This publication has 186 references indexed in Scilit:
- A CRISPR/Cas system mediates bacterial innate immune evasion and virulenceNature, 2013
- Re-emergence of tularemia in TurkeyInternational Journal of Infectious Diseases, 2009
- Identification of Undecaprenyl Phosphate-β-d-Galactosamine in Francisella novicida and Its Function in Lipid A ModificationBiochemistry, 2009
- Levofloxacin rescues mice from lethal intra-nasal infections with virulent Francisella tularensis and induces immunity and production of protective antibodyVaccine, 2008
- Galleria mellonella as a model host to study infection by the Francisella tularensis live vaccine strainMicrobes and Infection, 2007
- Attenuated virulence of a Francisella mutant lacking the lipid A 4′-phosphataseProceedings of the National Academy of Sciences of the United States of America, 2007
- A comprehensive transposon mutant library of Francisella novicida , a bioweapon surrogateProceedings of the National Academy of Sciences of the United States of America, 2007
- Structure and Biosynthesis of Free Lipid A Molecules That Replace Lipopolysaccharide in Francisella tularensis subsp. novicidaBiochemistry, 2006
- Deletion of TolC orthologs in Francisella tularensis identifies roles in multidrug resistance and virulenceProceedings of the National Academy of Sciences of the United States of America, 2006
- The complete genome sequence of Francisella tularensis, the causative agent of tularemiaNature Genetics, 2005